{{Rsnum
|rsid=13240755
|Gene=POR
|Chromosome=7
|position=75976791
|Orientation=plus
|GMAF=0.4688
|Gene_s=POR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 39.8 | 47.8 | 12.4
| HCB | 13.1 | 47.4 | 39.4
| JPT | 18.6 | 45.1 | 36.3
| YRI | 12.9 | 38.1 | 49.0
| ASW | 14.0 | 38.6 | 47.4
| CHB | 13.1 | 47.4 | 39.4
| CHD | 13.8 | 46.8 | 39.4
| GIH | 54.5 | 35.6 | 9.9
| LWK | 8.2 | 45.5 | 46.4
| MEX | 15.5 | 39.7 | 44.8
| MKK | 9.0 | 50.0 | 41.0
| TSI | 38.2 | 41.2 | 20.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=24273552
|Title=A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor
|OA=1
}}

{{on chip | Affy GenomeWide 6}}